Pure Global

Nitinol Stent System - India CDSCO Medical Device Registration

Nitinol Stent System is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID IMP/MD/2022/000230_d3f45bd0320504207a059bd641665ff3_88fe93e167abf9fb2c8e9108ad229b44. This device is marketed under the brand name OPTEASE®. The license holder is Cardinal Health Medical Products India Pvt Ltd, and it is classified as Device Class Class D. The approving authority is CDSCO.

This page provides comprehensive regulatory information including complete registration details, license holder information, device classification, and related products. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.

Free Database
Powered by Pure Global AI
CDSCO Registered
Class Class D
Nitinol Stent System
UID: IMP/MD/2022/000230_d3f45bd0320504207a059bd641665ff3_88fe93e167abf9fb2c8e9108ad229b44

Brand Name

OPTEASE®

Device Class

Class D

Approving Authority

CDSCO

Product Information

The Cordis PRECISE® PRO Rx Nitinol Stent System is indicated for use in patients with stenotic lesions of the carotid artery(OPTEASE®)

Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing